← 返回產品資料庫

美堅迪爾埃狄各新試劑

🩺 醫材

MGC DRI Digoxin Assay

衛署醫器輸字第021355號

醫材分類

2 等級
  • A.3320毛地黃毒素試驗系統

醫器規格

#1669 DRI Digoxin Assay (25 ml,8 ml kit)。

限制項目

輸 入

適應症

定量測定人類血清及血漿中的毛地黃素(digoxin)含量。

醫材資訊

主成分
Antibody Reagent Contains: monoclonal anti-digoxin antibody in a buffer solution with sodium azide as a preservative. Microparticles Reagent Contains: digoxin coated microparticles suspension in an aqueous solution with sodium azide as a preservative. Calibrators: DRI Digoxin Negative Calibrator 1 x 5 mL (Contains 5 mL buffer solution with sodium azide as a preservative); DRI Digoxin 0.5 ng/mL Calibrator 1 x 2 mL (Contains 0.5 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 1.0 ng/mL Calibrator 1 x 2 mL (Contains 1.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 2.0 ng/mL Calibrator 1 x 2 mL (Contains 2.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 3.0 ng/mL Calibrator 1 x 2 mL (Contains 3.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 5.0 ng/mL Calibrator 1 x 2 mL (Contains 5.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative).
製造商
MICROGENICS CORPORATION
製造國
US
申請商
醫全實業股份有限公司
有效日期
2030/07/19
發證日期
2010/07/19

供應藥局

目前尚無登錄供應此品項的藥局資料。